Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001214659-19-002838
Filing Date
2019-04-23
Accepted
2019-04-22 20:46:30
Documents
1
Effectiveness Date
2019-04-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8377
  Complete submission text file 0001214659-19-002838.txt   9505
Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: D | Act: 33 | File No.: 021-337858 | Film No.: 19760453
SIC: 2834 Pharmaceutical Preparations